View in EDS

Personalized allele-specific antisense oligonucleotides for GNAO1-neurodevelopmental disorder.

Saved in:
Bibliographic Details
Title: Personalized allele-specific antisense oligonucleotides for GNAO1-neurodevelopmental disorder.
Authors: Shomer I; Cancer Research Center and Wohl Institute for Translational Medicine, Tel Hashomer, Ramat Gan, Israel., Mor N; Cancer Research Center and Wohl Institute for Translational Medicine, Tel Hashomer, Ramat Gan, Israel., Raviv S; Cancer Research Center and Wohl Institute for Translational Medicine, Tel Hashomer, Ramat Gan, Israel., Budick-Harmelin N; Cancer Research Center and Wohl Institute for Translational Medicine, Tel Hashomer, Ramat Gan, Israel., Matchevich T; Cancer Research Center and Wohl Institute for Translational Medicine, Tel Hashomer, Ramat Gan, Israel., Avkin-Nachum S; Cancer Research Center and Wohl Institute for Translational Medicine, Tel Hashomer, Ramat Gan, Israel., Rais Y; Cancer Research Center and Wohl Institute for Translational Medicine, Tel Hashomer, Ramat Gan, Israel., Haffner-Krausz R; Department of Veterinary Resources, Weizmann Institute of Science, Rehovot, Israel., Haimovich A; Cancer Research Center and Wohl Institute for Translational Medicine, Tel Hashomer, Ramat Gan, Israel., Ziv A; Cancer Research Center and Wohl Institute for Translational Medicine, Tel Hashomer, Ramat Gan, Israel., Fluss R; Cancer Research Center and Wohl Institute for Translational Medicine, Tel Hashomer, Ramat Gan, Israel., Ben-Ze'ev B; Sheba Medical Center, Edmond and Lilly Safra Children's Hospital, Tel Hashomer, Israel., Heimer G; Sheba Medical Center, Edmond and Lilly Safra Children's Hospital, Tel Hashomer, Israel., Silachev DN; Institute of Life Sciences and Biomedicine, Far Eastern Federal University, 690090 Vladivostok, Russia.; A.N. Belozersky Research Institute of Physico-Chemical Biology, Moscow State University, 119992 Moscow, Russia.; Department of Cell Physiology and Metabolism, Faculty of Medicine, Translational Research Center in Oncohaematology, University of Geneva, 1211 Geneva, Switzerland., Katanaev VL; Institute of Life Sciences and Biomedicine, Far Eastern Federal University, 690090 Vladivostok, Russia.; Department of Cell Physiology and Metabolism, Faculty of Medicine, Translational Research Center in Oncohaematology, University of Geneva, 1211 Geneva, Switzerland., Dominissini D; Cancer Research Center and Wohl Institute for Translational Medicine, Tel Hashomer, Ramat Gan, Israel.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Source: Molecular therapy. Nucleic acids [Mol Ther Nucleic Acids] 2024 Dec 22; Vol. 36 (1), pp. 102432. Date of Electronic Publication: 2024 Dec 22 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101581621 Publication Model: eCollection Cited Medium: Print ISSN: 2162-2531 (Print) Linking ISSN: 21622531 NLM ISO Abbreviation: Mol Ther Nucleic Acids Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39897576
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Personalized allele-specific antisense oligonucleotides for GNAO1-neurodevelopmental disorder.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Shomer+I%22">Shomer I</searchLink>; Cancer Research Center and Wohl Institute for Translational Medicine, Tel Hashomer, Ramat Gan, Israel.<br /><searchLink fieldCode="AU" term="%22Mor+N%22">Mor N</searchLink>; Cancer Research Center and Wohl Institute for Translational Medicine, Tel Hashomer, Ramat Gan, Israel.<br /><searchLink fieldCode="AU" term="%22Raviv+S%22">Raviv S</searchLink>; Cancer Research Center and Wohl Institute for Translational Medicine, Tel Hashomer, Ramat Gan, Israel.<br /><searchLink fieldCode="AU" term="%22Budick-Harmelin+N%22">Budick-Harmelin N</searchLink>; Cancer Research Center and Wohl Institute for Translational Medicine, Tel Hashomer, Ramat Gan, Israel.<br /><searchLink fieldCode="AU" term="%22Matchevich+T%22">Matchevich T</searchLink>; Cancer Research Center and Wohl Institute for Translational Medicine, Tel Hashomer, Ramat Gan, Israel.<br /><searchLink fieldCode="AU" term="%22Avkin-Nachum+S%22">Avkin-Nachum S</searchLink>; Cancer Research Center and Wohl Institute for Translational Medicine, Tel Hashomer, Ramat Gan, Israel.<br /><searchLink fieldCode="AU" term="%22Rais+Y%22">Rais Y</searchLink>; Cancer Research Center and Wohl Institute for Translational Medicine, Tel Hashomer, Ramat Gan, Israel.<br /><searchLink fieldCode="AU" term="%22Haffner-Krausz+R%22">Haffner-Krausz R</searchLink>; Department of Veterinary Resources, Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Haimovich+A%22">Haimovich A</searchLink>; Cancer Research Center and Wohl Institute for Translational Medicine, Tel Hashomer, Ramat Gan, Israel.<br /><searchLink fieldCode="AU" term="%22Ziv+A%22">Ziv A</searchLink>; Cancer Research Center and Wohl Institute for Translational Medicine, Tel Hashomer, Ramat Gan, Israel.<br /><searchLink fieldCode="AU" term="%22Fluss+R%22">Fluss R</searchLink>; Cancer Research Center and Wohl Institute for Translational Medicine, Tel Hashomer, Ramat Gan, Israel.<br /><searchLink fieldCode="AU" term="%22Ben-Ze'ev+B%22">Ben-Ze'ev B</searchLink>; Sheba Medical Center, Edmond and Lilly Safra Children's Hospital, Tel Hashomer, Israel.<br /><searchLink fieldCode="AU" term="%22Heimer+G%22">Heimer G</searchLink>; Sheba Medical Center, Edmond and Lilly Safra Children's Hospital, Tel Hashomer, Israel.<br /><searchLink fieldCode="AU" term="%22Silachev+DN%22">Silachev DN</searchLink>; Institute of Life Sciences and Biomedicine, Far Eastern Federal University, 690090 Vladivostok, Russia.; A.N. Belozersky Research Institute of Physico-Chemical Biology, Moscow State University, 119992 Moscow, Russia.; Department of Cell Physiology and Metabolism, Faculty of Medicine, Translational Research Center in Oncohaematology, University of Geneva, 1211 Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Katanaev+VL%22">Katanaev VL</searchLink>; Institute of Life Sciences and Biomedicine, Far Eastern Federal University, 690090 Vladivostok, Russia.; Department of Cell Physiology and Metabolism, Faculty of Medicine, Translational Research Center in Oncohaematology, University of Geneva, 1211 Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Dominissini+D%22">Dominissini D</searchLink>; Cancer Research Center and Wohl Institute for Translational Medicine, Tel Hashomer, Ramat Gan, Israel.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101581621%22">Molecular therapy. Nucleic acids</searchLink> [Mol Ther Nucleic Acids] 2024 Dec 22; Vol. 36 (1), pp. 102432. <i>Date of Electronic Publication: </i>2024 Dec 22 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101581621 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2162-2531 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221622531%22">21622531 </searchLink><i>NLM ISO Abbreviation: </i>Mol Ther Nucleic Acids <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39897576
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.omtn.2024.102432
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 102432
    Titles:
      – TitleFull: Personalized allele-specific antisense oligonucleotides for GNAO1-neurodevelopmental disorder.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Shomer I
      – PersonEntity:
          Name:
            NameFull: Mor N
      – PersonEntity:
          Name:
            NameFull: Raviv S
      – PersonEntity:
          Name:
            NameFull: Budick-Harmelin N
      – PersonEntity:
          Name:
            NameFull: Matchevich T
      – PersonEntity:
          Name:
            NameFull: Avkin-Nachum S
      – PersonEntity:
          Name:
            NameFull: Rais Y
      – PersonEntity:
          Name:
            NameFull: Haffner-Krausz R
      – PersonEntity:
          Name:
            NameFull: Haimovich A
      – PersonEntity:
          Name:
            NameFull: Ziv A
      – PersonEntity:
          Name:
            NameFull: Fluss R
      – PersonEntity:
          Name:
            NameFull: Ben-Ze'ev B
      – PersonEntity:
          Name:
            NameFull: Heimer G
      – PersonEntity:
          Name:
            NameFull: Silachev DN
      – PersonEntity:
          Name:
            NameFull: Katanaev VL
      – PersonEntity:
          Name:
            NameFull: Dominissini D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 22
              M: 12
              Text: 2024 Dec 22
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 2162-2531
          Numbering:
            – Type: volume
              Value: 36
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Molecular therapy. Nucleic acids
              Type: main
ResultId 1